Our expertise

Financing

Companies in the biotech industry are highly dependent on funding in the form of equity, loans, and subsidies. Axon Lawyers has assisted many biotech companies in this field. Our advice comprises:

  • Strategic advice on the most suitable form of financing, taking into account the phase of the company and the business model
  • Equity financing: investment agreements, shareholder agreements, and stock options plans
  • Subsidies and grants: drafting and/or reviewing of consortium agreements for subsidised research projects (FP7, Transbio, PiD, Eurostar, CTMM, TI Pharma, TTI GG, NanonextNL, etc.), advice on governmental support issues, and advice on terms for innovation credits and other governmental loans and grants
  • Commercial loans: Commercial loan agreements (including BBMKB), security agreements (pledge, surety, etc.)
Axon Advocaten

Your business

business

IVDs

Building on our thorough understanding of both the IVD sector and the (inter)national regulatory framework,...

Read more

business

Medical Devices

Our internationally recognized medical technology practice advises leading established as well as startup innovative medical...

Read more

business

Clinical Trials

We advise a large number of companies and institutions active in pharmaceuticals, medical devices and...

Read more

business

Food

Axon Lawyers assists food business operators in all their needs regarding the manufacturing and marketing...

Read more

business

eHealth and mHealth

In the fast expanding market for eHealth, mHealth and telemedicine, we provide our clients with...

Read more